Trials / Conditions / Solid Tumors (Phase 1)
Solid Tumors (Phase 1)
6 registered clinical trials studyying Solid Tumors (Phase 1) — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors NCT07362888 | Adcendo ApS | Phase 1 |
| Recruiting | Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS M NCT07252479 | Adlai Nortye Biopharma Co., Ltd. | Phase 1 |
| Enrolling By Invitation | A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid T NCT07218003 | Rondo Therapeutics | Phase 1 |
| Recruiting | A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors NCT07288957 | Abbisko Therapeutics Co, Ltd | Phase 1 |
| Not Yet Recruiting | Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors NCT06652529 | Aromics Therapeutics | Phase 1 |
| Terminated | Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme NCT02765165 | Proximagen, LLC | Phase 1 / Phase 2 |